Neurogene (NGNE) Other Working Capital Changes (2020 - 2026)
Neurogene (NGNE) posted Other Working Capital Changes of -$755000.0 for Q1 2026, down 2.03% on a QoQ basis from -$740000.0 in Q4 2025, and down 6.94% year-over-year from -$811309.0 in Q1 2025.
Neurogene (NGNE) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Neurogene's Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$755000.0 for Q1 2026.
- Quarterly Other Working Capital Changes fell 6.94% year-over-year to -$755000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.0 million (down 11.12% YoY) and the FY2025 annual result came in at -$2.9 million, down 13.41% from the prior year.
- Other Working Capital Changes was -$755000.0 for Q1 2026 at Neurogene, down from -$740000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.4 million in Q1 2024 and bottomed at -$1.4 million in Q2 2024.
- A 5-year average of -$60117.6 and a median of -$33000.0 in 2025 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes soared 195.77% — and 2024, when it plunged 284.71%.
- Neurogene's Other Working Capital Changes stood at $249000.0 in 2022, then slumped by 171.08% to -$177000.0 in 2023, then slumped by 283.05% to -$678000.0 in 2024, then fell by 9.14% to -$740000.0 in 2025, then declined by 2.03% to -$755000.0 in 2026.
- Business Quant data shows NGNE's Other Working Capital Changes at -$755000.0 in Q1 2026, -$740000.0 in Q4 2025, and -$745000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Neurogene | 776.69 Mn | 776.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -755,000.00 |
| Mar 31, 2026 | -755,000.00 |
| Mar 31, 2026 | -755,000.00 |
| Dec 31, 2025 | -740,000.00 |
| Dec 31, 2025 | -740,000.00 |
| Dec 31, 2025 | -740,000.00 |
| Sep 30, 2025 | -745,000.00 |
| Sep 30, 2025 | -745,000.00 |
| Sep 30, 2025 | -745,000.00 |
| Jun 30, 2025 | -727,000.00 |
| Jun 30, 2025 | -727,000.00 |
| Jun 30, 2025 | -727,000.00 |
| Mar 31, 2025 | -706,000.00 |
| Mar 31, 2025 | -706,000.00 |
| Mar 31, 2025 | -706,000.00 |
| Dec 31, 2024 | -678,000.00 |
| Dec 31, 2024 | -678,000.00 |
| Dec 31, 2024 | -678,000.00 |
| Sep 30, 2024 | -654,000.00 |
| Sep 30, 2024 | -654,000.00 |